Outbreak of vancomycin-resistant Enterococcus colonization among pediatric oncology patients\

Infection Control and Hospital Epidemiology

Volumn 30, Issue 4, 2009, Pages 338-345

  Nolan, Sheila M ^a   Gerber, Jeffrey S ^a   Zaoutis, Theoklis ^a   Prasad, Priya ^a   Rettig, Susan ^a   Gross, Kimberly ^a   McGowan, Karin L ^a   Reilly, Anne F ^a   Coffin, Susan E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; CANCER PATIENT; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DEVICE; ELECTRONIC MEDICAL RECORD; EPIDEMIC; FECES ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; STAFF TRAINING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INFECTION CONTROL; MALE; ONCOLOGY SERVICE, HOSPITAL; PHILADELPHIA; PREVALENCE; RISK FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 63449138520     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/596202     Document Type: Article

References (29)

1. Raad I, Hachem R, Hanna H, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007; 26:549-556.
2. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172:993-1000.
3. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in healthcare facilities in a region. N Engl J Med 2001; 344:1427-1433.
4. Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 2002; 23:102-103.
5. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996; 15:848-854.
6. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172:993-1000.
7. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158:1127-1132.
8. Ofner-Agostini ME, Conly J, Paton S, et al. Vancomycin-resistant enterococci (VRE) in Canada - results of the Canadian Nosocomial Infection Surveillance Program 1996: VRE point prevalence surveillance project. Can J Infect Dis 1997; 8:73-78.
9. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167-172.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. CLSI document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
11. Sakka V, Tsiodras S, Galani L, et al. Risk factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008; 14:14-21.
12. Mody L, Maheshwari S, Galecki A, Kauffman CA, Bradley SF. Indwelling device use and antibiotic resistance in nursing homes: identifying a high-risk group. J Am Geriatr Soc 2007; 55:1921-1926.
13. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001; 22:217-219.
14. Timmers GJ, van der Zwet WC, Simoons-Smit IM, et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 2002; 116:826-833.
15. Christiansen KJ, Tibbett PA, Beresford W, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004; 25:384-390.
16. Peta M, Carretto E, Barbarini D, et al. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect 2006; 12:163-169.
17. Schmidt-Hieber M, Blau IW, Schwartz S, et al. Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol 2007; 86:158-162.
18. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386.
19. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
20. Hwang YS, Brinton BG, Leonard RB, Blue SR, Woods ML, Carroll KC. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium in a low prevalence university hospital. J Investig Med 1998; 46: 435-443.
21. Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003; 163:1905-1912.
22. Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006; 42:739-746.
23. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006; 34:447-451.
24. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001; 22:140-147.
25. Chavers LS, Moser SA, Funkhouser E, et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. Microb Drug Resist 2003; 9(Suppl 1):S69-77.
26. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36:145-158.
27. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003; 36:440-446.
28. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002; 8:802-807.
29. Fridkin SK, Edwards JR, Courval JM, et al.; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001; 135:175-183.